IL-2-anti-IL-2 complexes in immunity to blood stage malaria infection and prevention of cerebral immunopathology [ 2010 - 2012 ]

Also known as: Modifying the host immune response to malaria to control parasite burden and prevent cerebral malaria simultaneously.

Research Grant

[Cite as]

Researchers: A/Pr Ashraful Haque (Principal investigator)

Brief description Cerebral malaria is a severe complication of malaria infection, which accounts for a large proportion of malaria-related deaths each year. There is no vaccine against malaria licensed for use in humans. Trial vaccines have been shown to protect poorly against cerebral malaria, and have on occasion, increased the its incidence amongst experimental animals. We aim to develop a safe malaria vaccine that controls malaria parasite numbers in the body, and also prevents cerebral malaria.

Funding Amount $AUD 586,428.38

Funding Scheme NHMRC Project Grants

Notes New Investigator Grant

Click to explore relationships graph
Viewed: [[ro.stat.viewed]]